Michael Glode, MD
Professor Emeritus, Medicine-Medical Oncology

Photo
Medical School:
  • MD, Washington University in St. Louis School of Medicine (1972)
Undergraduate School:
  • BS, University of Nebraska–Lincoln (NE) (1968)
Internship:
  • University of Texas Southwestern Medical School Program (1973)
Residency:
  • University of Texas Southwestern Medical School Program, Internal Medicine (1974)
Fellowships:
  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute Program, Medical Oncology (1978)
  • National Institutes of Health (NIH), Internal Medicine (1976)
  • National Institutes of Health (NIH), Cancer / Oncology (1986)
Languages: English
Department: Medicine-Medical Oncology

Professional Titles

  • Emeritus Professor

Recognition & Awards

  • Fellow American Society of Clinical Oncology, ASCO (2011)
  • Statesman Award, American Society of Clinical Oncology (2009)
  • Fellow, American College of Physicians (2008)

Research Interests

I work with a number of pharmaceutical companies on clinical trials for patients with genitourinary malignancies

Teaching

  • Professor of Medicine (1978)
    School of Medicine, Medicine
    Medical Oncology - Genitourinary Malignancies (prostate, kidney, testis, bladder)
  • Staff Physician (2004)
    School of Medicine, Medicine
    Weekly Clinic at Shaw Cancer Center, Edwards, Colorado

Publications

  • Wittmann D, Skolarus T, Glodé LM. Reconsidering the Trade-offs of Prostate Cancer Screening. N Engl J Med. 2020 Sep 24;383(13):1289-1290. PubMed PMID: 32966735
  • Goren A, Wambier CG, McCoy J, Shapiro J, Vaño-Galván S, Herrera S, Glode LM. Clock genes may drive seasonal variation in SARS-CoV-2 infectivity: are we due for a second wave of COVID-19 in the fall?. J Biol Regul Homeost Agents. 2020 Jul-Aug,;34(4):1455-1457. PubMed PMID: 32700513
  • Halpern AL, Torphy RJ, McCarter MD, Sciotto CG, Glode LM, Robinson WA. A familial germline mutation in KIT associated with achalasia, mastocytosis and gastrointestinal stromal tumors shows response to kinase inhibitors. Cancer Genet. 2019 Apr;233-234:1-6. PubMed PMID: 31109590
  • Schlaepfer IR, Glodé LM, Hitz CA, Pac CT, Boyle KE, Maroni P, Deep G, Agarwal R, Lucia SM, Cramer SD, Serkova NJ, Eckel RH. Inhibition of Lipid Oxidation Increases Glucose Metabolism and Enhances 2-Deoxy-2-[(18)F]Fluoro-D-Glucose Uptake in Prostate Cancer Mouse Xenografts. Mol Imaging Biol. 2015 Jan 6. [Epub ahead of print] PubMed PMID: 25561013
  • Bourlon MT, Glodé LM, Crawford ED. Base of the skull metastases in metastatic castration-resistant prostate cancer. Oncology (Williston Park). 2014 Dec;28(12):1115-6, 1124. PubMed PMID: 25510811
  • Schlaepfer IR, Rider L, Rodrigues LU, Gijón MA, Pac CT, Romero L, Cimic A, Sirintrapun SJ, Glodé LM, Eckel RH, Cramer SD. Lipid catabolism via CPT1 as a therapeutic target for prostate cancer. Mol Cancer Ther. 2014 Oct;13(10):2361-71. PubMed PMID: 25122071
View All (6 Total) View Less

Professional Memberships

  • American Society of Clinical Oncology, Member
  • American Association for Cancer Research, Member
  • American College of Physicians (ACP), Fellow

Practice Locations

Hospital Affiliation
  • University of Colorado Hospital

Specialty Information

Specialties
  • Internal Medicine, Board Certification (1975)
  • Medical Oncology, Board Certification (1977)
  • Molecular Biology - University Helsinki Finland, Specialized Training (1986)
Conditions & Treatments
  • Cancers - Bladder Cancer
  • Cancers - Chemotherapy
  • Cancers - Kidney Cancer
  • Cancers - Prostate Cancer
  • Cancers - Testicular Cancer
  • Cancers
  • Cancers - Cancer Medicine
  • Cancers - Urologic Cancer
Clinical Interests
I see patients only at the Shaw Cancer Center in Vail (Edwards, CO 970-569-7429). I specialize in prostate cancer issues from screening to initial treatment to caring for patients with metastatic disease. I serve on several advisory boards for new medications used in GU cancers.

Care Philosophy
Patients facing cancer need expertise and experience as well as compassion. Finding options for further therapy is always a priority. I write a blog to help my patients (and others) keep up that you can access here: www.prost8blog.com. In addition, supporting a patient who has exhausted all options is a sacred trust, and life is a journey we all share. It is a privilege to be on that journey with my patients.

Personal Interests
My hobbies include golf, skiing, fly-fishing, and woodworking. Grandparenting is an increasingly lovely diversion as well!

Volunteer Activities
Global Prostate Cancer Outcomes Committee, Movember Foundation Volunteer, EPIC Experience

Public Speaking
Yes
I speak about prostate cancer, from screening to latest research findings

General Information

Medical Schools:
  • MD, Washington University in St. Louis School of Medicine (1972)
Undergraduate Schools:
  • BS, University of Nebraska–Lincoln (NE) (1968)
Internships:
  • University of Texas Southwestern Medical School Program (1973)
Residency Programs:
  • University of Texas Southwestern Medical School Program, Internal Medicine (1974)
Fellowships:
  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute Program, Medical Oncology (1978)
  • National Institutes of Health (NIH), Internal Medicine (1976)
  • National Institutes of Health (NIH), Cancer / Oncology (1986)
Languages: English
Department: Medicine-Medical Oncology
Contact Us
CU Anschutz
Fitzsimons Building

13001 East 17th Place
Campus Box C290
Aurora, CO 80045

Update My Profile
;